Cargando…
Oral and monoclonal antibody treatments for relapsing forms of multiple sclerosis: Effectiveness and value: A Summary from the Institute for Clinical and Economic Review’s New England Comparative Effectiveness Public Advisory Council
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Academy of Managed Care Pharmacy
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387920/ https://www.ncbi.nlm.nih.gov/pubmed/37404068 http://dx.doi.org/10.18553/jmcp.2023.29.7.857 |
| _version_ | 1785081991568293888 |
|---|---|
| author | McKenna, Avery Lin, Grace A Whittington, Melanie D Nikitin, Dmitriy Herron-Smith, Serina Campbell, Jonathan D Agboola, Foluso Pearson, Steven D |
| author_facet | McKenna, Avery Lin, Grace A Whittington, Melanie D Nikitin, Dmitriy Herron-Smith, Serina Campbell, Jonathan D Agboola, Foluso Pearson, Steven D |
| author_sort | McKenna, Avery |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10387920 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Academy of Managed Care Pharmacy |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103879202023-07-31 Oral and monoclonal antibody treatments for relapsing forms of multiple sclerosis: Effectiveness and value: A Summary from the Institute for Clinical and Economic Review’s New England Comparative Effectiveness Public Advisory Council McKenna, Avery Lin, Grace A Whittington, Melanie D Nikitin, Dmitriy Herron-Smith, Serina Campbell, Jonathan D Agboola, Foluso Pearson, Steven D J Manag Care Spec Pharm Perspectives on Value Academy of Managed Care Pharmacy 2023-07 /pmc/articles/PMC10387920/ /pubmed/37404068 http://dx.doi.org/10.18553/jmcp.2023.29.7.857 Text en Copyright © 2023, Academy of Managed Care Pharmacy. All rights reserved. https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use and redistribution provided that the original author and source are credited. |
| spellingShingle | Perspectives on Value McKenna, Avery Lin, Grace A Whittington, Melanie D Nikitin, Dmitriy Herron-Smith, Serina Campbell, Jonathan D Agboola, Foluso Pearson, Steven D Oral and monoclonal antibody treatments for relapsing forms of multiple sclerosis: Effectiveness and value: A Summary from the Institute for Clinical and Economic Review’s New England Comparative Effectiveness Public Advisory Council |
| title | Oral and monoclonal antibody treatments for relapsing forms of multiple sclerosis: Effectiveness and value: A Summary from the Institute for Clinical and Economic Review’s New England Comparative Effectiveness Public Advisory Council |
| title_full | Oral and monoclonal antibody treatments for relapsing forms of multiple sclerosis: Effectiveness and value: A Summary from the Institute for Clinical and Economic Review’s New England Comparative Effectiveness Public Advisory Council |
| title_fullStr | Oral and monoclonal antibody treatments for relapsing forms of multiple sclerosis: Effectiveness and value: A Summary from the Institute for Clinical and Economic Review’s New England Comparative Effectiveness Public Advisory Council |
| title_full_unstemmed | Oral and monoclonal antibody treatments for relapsing forms of multiple sclerosis: Effectiveness and value: A Summary from the Institute for Clinical and Economic Review’s New England Comparative Effectiveness Public Advisory Council |
| title_short | Oral and monoclonal antibody treatments for relapsing forms of multiple sclerosis: Effectiveness and value: A Summary from the Institute for Clinical and Economic Review’s New England Comparative Effectiveness Public Advisory Council |
| title_sort | oral and monoclonal antibody treatments for relapsing forms of multiple sclerosis: effectiveness and value: a summary from the institute for clinical and economic review’s new england comparative effectiveness public advisory council |
| topic | Perspectives on Value |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387920/ https://www.ncbi.nlm.nih.gov/pubmed/37404068 http://dx.doi.org/10.18553/jmcp.2023.29.7.857 |
| work_keys_str_mv | AT mckennaavery oralandmonoclonalantibodytreatmentsforrelapsingformsofmultiplesclerosiseffectivenessandvalueasummaryfromtheinstituteforclinicalandeconomicreviewsnewenglandcomparativeeffectivenesspublicadvisorycouncil AT lingracea oralandmonoclonalantibodytreatmentsforrelapsingformsofmultiplesclerosiseffectivenessandvalueasummaryfromtheinstituteforclinicalandeconomicreviewsnewenglandcomparativeeffectivenesspublicadvisorycouncil AT whittingtonmelanied oralandmonoclonalantibodytreatmentsforrelapsingformsofmultiplesclerosiseffectivenessandvalueasummaryfromtheinstituteforclinicalandeconomicreviewsnewenglandcomparativeeffectivenesspublicadvisorycouncil AT nikitindmitriy oralandmonoclonalantibodytreatmentsforrelapsingformsofmultiplesclerosiseffectivenessandvalueasummaryfromtheinstituteforclinicalandeconomicreviewsnewenglandcomparativeeffectivenesspublicadvisorycouncil AT herronsmithserina oralandmonoclonalantibodytreatmentsforrelapsingformsofmultiplesclerosiseffectivenessandvalueasummaryfromtheinstituteforclinicalandeconomicreviewsnewenglandcomparativeeffectivenesspublicadvisorycouncil AT campbelljonathand oralandmonoclonalantibodytreatmentsforrelapsingformsofmultiplesclerosiseffectivenessandvalueasummaryfromtheinstituteforclinicalandeconomicreviewsnewenglandcomparativeeffectivenesspublicadvisorycouncil AT agboolafoluso oralandmonoclonalantibodytreatmentsforrelapsingformsofmultiplesclerosiseffectivenessandvalueasummaryfromtheinstituteforclinicalandeconomicreviewsnewenglandcomparativeeffectivenesspublicadvisorycouncil AT pearsonstevend oralandmonoclonalantibodytreatmentsforrelapsingformsofmultiplesclerosiseffectivenessandvalueasummaryfromtheinstituteforclinicalandeconomicreviewsnewenglandcomparativeeffectivenesspublicadvisorycouncil |